GoodRx reports that Foundayo, a new oral weight-loss pill, is FDA-approved for obesity treatment, offering an alternative to ...

The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...

Weight loss patients "now have options" after a study found they can switch from an injectable GLP-1 medication to pills ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

The Food and Drug Administration has approved the second GLP-1 pill to treat obesity, this time from drugmaker Eli Lilly. The new pill, Foundayo, is taken once a day and will compete with the pill ...

Eli Lilly said the highest dose of its daily obesity pill helped patients lose almost 12% of their body weight, or roughly 27 pounds, at 72 weeks in a late-stage trial. They bring Eli Lilly's pill, ...